ROE của cổ phiếu QDEL là bao nhiêu?

QUIDEL CORPORATION có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) -65.40%.

Tỷ suất cổ tức của QDEL là bao nhiêu?

QUIDEL CORPORATION có tỷ suất cổ tức 0.00%.

Điểm chất lượng (Quality Score) của QDEL là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của QDEL ở mức 54/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu QDEL không?

Điểm AI Timing của QDEL là 94/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu QDEL thuộc ngành nào?

QUIDEL CORPORATION được xếp vào ngành Healthcare >> Medical Devices trên sàn NASDAQ

Cổ phiếu QDEL (NASDAQ) | QUIDEL CORPORATION

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

QDEL AI Analysis Summary

Our AI summary for QDEL: QUIDEL CORPORATION (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -65.40%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 94/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

QDEL

QUIDEL CORPORATION

US:NASDAQ STOCK Healthcare >> Medical Devices News 99

USD 16.77

0.20 (1.21%) Day Change

Watchlist Portfolio Compare Chart

1.47

D/E

-65.4%

ROE

-21.5%

ROA

0.00%

Div Yield

QUIDEL CORPORATION
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 16.77 Price 0.20 (1.21%) Day Change	NEWS SCORE: 99

QDEL Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	16.77
PBV / Sector	0.61 / -101.57 GREAT
Earning Per Share	-17.97

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	18.21 M GREAT
Average 1W Daily Value	16.30 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

43%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-45.57 / 20.50
NPM Average (%) / Sector	-28.86 / -15.37
NPM Change Average (%) / Sector	5,412.47 / 7.34 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-21.51 / 39.11
ROA Average (%) / Sector	-13.40 / 5.58
ROA Change Average (%) / Sector	6,713.23 / 104.50 GREAT
ROE (%) / Sector	-65.40 / -166.42
ROE Average (%) / Sector	-36.43 / -16.93
ROE Change Average (%) / Sector	8,468.07 / -500.08 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Chi tiết đăng ký

Analyze Date	2026-08-01 08:00:22
Symbol	QDEL
Name	QUIDEL CORPORATION
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	68.19 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,129.92 / 20,104.97

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 9975 Summers Ridge Road, San Diego, CA, United States, 92121

Phone: 858 552 1100

Website: https://www.quidelortho.com

Employees: 6,500

Sector: Healthcare >> Medical Devices

Description: QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.